JP2010529468A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529468A5
JP2010529468A5 JP2010511540A JP2010511540A JP2010529468A5 JP 2010529468 A5 JP2010529468 A5 JP 2010529468A5 JP 2010511540 A JP2010511540 A JP 2010511540A JP 2010511540 A JP2010511540 A JP 2010511540A JP 2010529468 A5 JP2010529468 A5 JP 2010529468A5
Authority
JP
Japan
Prior art keywords
individual
hbp
risk
determining whether
severe sepsis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010511540A
Other languages
English (en)
Japanese (ja)
Other versions
JP5166522B2 (ja
JP2010529468A (ja
Filing date
Publication date
Priority claimed from GBGB0711327.7A external-priority patent/GB0711327D0/en
Application filed filed Critical
Publication of JP2010529468A publication Critical patent/JP2010529468A/ja
Publication of JP2010529468A5 publication Critical patent/JP2010529468A5/ja
Application granted granted Critical
Publication of JP5166522B2 publication Critical patent/JP5166522B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010511540A 2007-06-12 2008-06-12 診断方法 Active JP5166522B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0711327.7A GB0711327D0 (en) 2007-06-12 2007-06-12 Diagnostic method
GB0711327.7 2007-06-12
PCT/EP2008/004743 WO2008151808A1 (en) 2007-06-12 2008-06-12 Diagnostic method

Publications (3)

Publication Number Publication Date
JP2010529468A JP2010529468A (ja) 2010-08-26
JP2010529468A5 true JP2010529468A5 (cg-RX-API-DMAC7.html) 2011-07-28
JP5166522B2 JP5166522B2 (ja) 2013-03-21

Family

ID=38331957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010511540A Active JP5166522B2 (ja) 2007-06-12 2008-06-12 診断方法

Country Status (16)

Country Link
US (3) US8518648B2 (cg-RX-API-DMAC7.html)
EP (1) EP2129391B1 (cg-RX-API-DMAC7.html)
JP (1) JP5166522B2 (cg-RX-API-DMAC7.html)
KR (1) KR101563997B1 (cg-RX-API-DMAC7.html)
CN (2) CN103543271A (cg-RX-API-DMAC7.html)
AT (1) ATE548050T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008261252B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0812875B8 (cg-RX-API-DMAC7.html)
CA (1) CA2690067C (cg-RX-API-DMAC7.html)
DK (1) DK2129391T3 (cg-RX-API-DMAC7.html)
ES (1) ES2380875T3 (cg-RX-API-DMAC7.html)
GB (1) GB0711327D0 (cg-RX-API-DMAC7.html)
PL (1) PL2129391T3 (cg-RX-API-DMAC7.html)
PT (1) PT2129391E (cg-RX-API-DMAC7.html)
SI (1) SI2129391T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008151808A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5488885B2 (ja) * 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
GB201016161D0 (en) * 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
EP2643483A4 (en) * 2010-11-26 2014-04-30 Immunexpress Pty Ltd DIAGNOSTIC AND / OR SCREENING APPROPRIATIONS AND USES THEREFOR
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
WO2013040379A1 (en) * 2011-09-16 2013-03-21 Cepheid Methods of detecting sepsis
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
WO2016057945A1 (en) 2014-10-09 2016-04-14 Texas Tech University System Micro-device to detect infection
CN109541235A (zh) * 2018-08-19 2019-03-29 重庆早柒天生物科技股份有限公司 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法
WO2020218121A1 (ja) 2019-04-24 2020-10-29 公益財団法人がん研究会 癌を検出する方法および検出試薬
CN111208305B (zh) * 2020-02-16 2023-04-25 重庆翼锋生物科技有限公司 Hbp和pct在败血症诊断试剂制备中的用途
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) * 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
NZ332683A (en) * 1994-04-21 2001-06-29 Novo Nordisk As Use of heparin binding protein to prevent or treat sepsis
US5976536A (en) 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
WO2003076459A1 (en) 2002-03-08 2003-09-18 Heloise, Anne, Pereira, Ph. D. An early detection marker for chronic inflammatory associated diseases
US7655480B2 (en) * 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
WO2004016653A2 (en) 2002-08-15 2004-02-26 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase
CA2516836A1 (en) * 2003-02-24 2004-09-10 Gtc Biotherapeutics, Inc. Methods of tangential flow filtration and an apparatus therefore
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2004112713A2 (en) 2003-06-20 2004-12-29 Royer Biomedical, Inc. Drug polymer complexes
US20070269437A1 (en) 2003-09-19 2007-11-22 Leukotech A/S Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
US20050196817A1 (en) * 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
WO2006113529A2 (en) * 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
CA2624569A1 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Similar Documents

Publication Publication Date Title
JP2010529468A5 (cg-RX-API-DMAC7.html)
Du et al. Combining central venous-to-arterial partial pressure of carbon dioxide difference and central venous oxygen saturation to guide resuscitation in septic shock
Davies Peritoneal solute transport and inflammation
Koenig et al. Usefulness of whole blood, plasma, peritoneal fluid, and peritoneal fluid supernatant glucose concentrations obtained by a veterinary point-of-care glucometer to identify septic peritonitis in dogs with peritoneal effusion
JP2020519904A5 (cg-RX-API-DMAC7.html)
Yaroustovsky et al. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery
Spapen et al. Diagnostic markers of sepsis in the emergency department
Zhang et al. Intestinal mucosal permeability of children with cefaclor-associated serum sickness-like reactions
Davis et al. Urinary neutrophil gelatinase-associated lipocalin concentration changes after acute haemorrhage and colloid-mediated reperfusion in anaesthetized dogs
JP2010500535A5 (cg-RX-API-DMAC7.html)
Dhillon et al. Neutrophils, nitric oxide, and microvascular permeability in severe sepsis
Kashani et al. Association between kidney intracapsular pressure and ultrasound elastography
CN104049089A (zh) 一种检测纤维蛋白原的方法及试剂盒
Hahn Renal water conservation determines the increase in body weight after surgery: a randomized, controlled trial
Mandic et al. Body composition and inflammation in hemodialysis patients
Ayoola et al. Association between endothelial dysfunction, biomarkers of renal function, and disease severity in sickle cell disease
WO2007106556A2 (en) Method for performing a non-invasive blood gas test
CN205333654U (zh) 基于生物标志物的肾损伤早期检测试纸条
Derici et al. Does the urinary excretion of α1-microglobulin and albumin predict clinical disease activity in ulcerative colitis?
Khan Ideal biomarkers of acute kidney injury
Nanda et al. Plasma lactate as prognostic marker of septic shock with acute respiratory distress syndrome
CN105444862A (zh) 一种腹膜透析瘦体重检测装置
CN106198953B (zh) 白介素-33在制备诊断肺源性急性肺损伤试剂盒中的用途
Guglani et al. Photoacoustic imaging assessment of acute kidney injury associated with experimental necrotizing enterocolitis
Sen et al. Role of critical care in urological sepsis